Clinical trials
Phase 1 Hyperglycemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor Research Institute | 3 |
| Yale University | 3 |
| AstraZeneca | 2 |
| Duke University | 2 |
| Yabao Pharmaceutical Group | 2 |
| Addis Ababa University | 1 |
| Albert Einstein College of Medicine | 1 |
| B & Y Technologies | 1 |
| Bows Pharmaceuticals AG | 1 |
| Caroline Medical Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 43 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 9 |
| Hypoglycemia | 6 |
| Diabetes Mellitus, Type 1 | 5 |
| Insulin Resistance | 4 |
| Glucose Intolerance | 3 |
| Hyperlipidemias | 3 |
| Hypertension | 3 |
| Metabolic Syndrome | 3 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.